Price
Target price
€13.50
€13.50
5.510%
0.7
5.510%
€25.00
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Syndax Pharmaceuticals Inc Stock
Syndax Pharmaceuticals Inc dominated the market today, gaining €0.70 (5.510%).
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Syndax Pharmaceuticals Inc stock is not clear.
As a result the target price of 25 € shows a very positive potential of 85.19% compared to the current price of 13.5 € for Syndax Pharmaceuticals Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Syndax Pharmaceuticals Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Syndax Pharmaceuticals Inc in the next few years
Pros
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Syndax Pharmaceuticals Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc | 5.510% | 25.000% | 69.811% | -24.157% | 9.756% | -42.308% | - |
| Pacira Pharmaceuticals | 0.000% | 5.000% | 7.692% | 89.189% | 13.514% | -62.162% | -58.416% |
| Rockwell Medical Inc. | 1.590% | 8.897% | -2.669% | -57.814% | -55.680% | -48.943% | -94.156% |
| Twist Bioscience Corp | -1.170% | 9.079% | -23.374% | -41.390% | -47.452% | -54.737% | -57.089% |
News
Syndax (SNDX) Q2 Revenue Jumps 986%
Syndax Pharmaceuticals (NASDAQ:SNDX), a biopharmaceutical company specializing in oncology therapeutics, reported its second-quarter 2025 earnings on August 4, 2025. The most notable news was its
